Presentation and Status in Health Basket
| Presentation | Basket | Yarpa | Pharmasoft |
|---|---|---|---|
|
Soluble Tablets 30 X 100 mg |
|
24397 | 6996 |
Related information
Dosage
PKU (Phenylketonuria): The starting dose in adult and paediatric patients with PKU is 10 mg/kg body weight once daily. The dose is adjusted, usually between 5 and 20 mg/kg/day, to achieve and maintain adequate blood phenylalanine levels.
BH4 deficiency: The starting dose in adult and paediatric patients with BH4 deficiency is 2 to5 mg/kg body weight total daily dose. Doses may be adjusted up to 20 mg/kg per day.
Please refer to the license holder for further details
Indications
Treatment of hyperphenylalaninaemia (HPA) in adults and paediatric patients of all ages with phenylketonuria (PKU) who have been shown to be responsive to such treatment.
Treatment of hyperphenylalaninaemia (HPA) in adults and paediatric patients of all ages with tetrahydrobiopterin (BH4) deficiency who have been shown to be responsive to such treatment.
Contra-Indications
Hypersensitivity to the active substance or to any of the excipients.
Special Precautions
Please refer to the license holder for further details.
Side Effects
Please refer to the license holder for further details.
Drug interactions
Please refer to the license holder for further details.
Pregnancy and Lactation
Please refer to the license holder for further details.
